Assessment of gait parameters and fatigue in MS patients during inpatient rehabilitation: a pilot trial

A pilot, randomized, open-label trial as

A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances

✍ Mark Weiser; Heschi H. Rotmensch; Amos D. Korczyn; Richard Hartman; Ana Cicin-Sa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## Background The majority of patients with Alzheimer's disease (AD) or vascular dementia display, in addition to cognitive impairment, various degrees of behavioral disturbances. As the use of cholinesterase inhibitors for the treatment of cognitive impairment in dementia becomes wide